Vestagen acquires new financing for research, expansion

Vestagen Protective Technologies Inc., developer of the VESTEX Active Barrier fabric line, announces that it has secured $9.5 million in financing. Existing investors Advent Life Sciences and HealthQuest Capital and new investors Greenline Ventures, Northwell Ventures and Mercy Health of Cincinnati, participated in the funding round.

The capital will be used primarily to generate additional clinical tests of VESTEX’s ability to protect health care workers and patients from the risks of unanticipated exposures to body fluids; to obtain regulatory review of the protective properties of VESTEX fabric; and to expand the company’s commercialization activities.

Vestagen develops advanced performance textile products and technologies including VESTEX Active Barrier protective fabrics combining antimicrobial, liquid-repellent and breathability properties.